Situation analysis of R and D activities: an empirical study in Iranian pharmaceutical companies

ABSTRACT

As global competition intensifies, research and development [R and D] organizations need to enhance their strategic management in order to become goal-directed communities for innovation and allocate their resources consistent with their overall R and D strategy. The world pharmaceutical market has undergone fast, unprecedented, tremendous and complex changes in the last several years. The pharmaceutical industry is today still one of the most inventive, innovative and lucrative of the so-called "high-tech" industries. This industry serves a dual role in modern society. On one hand, it is a growing industry, and its output makes a direct contribution to gross domestic product [GDP]. On the other side, drugs, this industry's major output, are an input in the production of good health. The purpose of this study is to evaluate R and D activities of pharmaceutical companies, and also to highlight critical factors which have influential effect on results of these activities. To run this study a valid questionnaire based on literature review and experts' opinion was designed and delivered to 11 pharmaceutical companies. Empirical data show there is not acceptable situations considering of the factors that should be taken in to account by managers including; management commitment, human resource management, information technology and financial management. Furthermore, we concluded some interesting results related to different aspects of R and D management. In conclusion, managers must be aware about their performance in R and D activities, accordingly they will able to take a comprehensive policy in both national and within the company